News Related to Bridion

Related coverage linked through entity extraction aliases.

Deutsche Bank upgrades Merck to Buy, citing path beyond Keytruda patent cliff

Apr 22, 2026

Deutsche Bank upgraded Merck to Buy and raised its price target to $150 from $115, citing a clear path beyond Keytruda’s patent expiration. Merck meanwhile forecast 2026 revenue of $65.5 billion to $67.0 billion and said it faces a $2.5 billion headwind this year.

Healthcare Sector Leads S&P 500 as Pharma Giants Navigate 2026 Market Shift

Mar 08, 2026

Healthcare sector surged 10% since Q4 2025, outpacing all S&P 500 sectors as investors rotate from tech to pharmaceutical value plays. Major drugmakers demonstrate resilience following Medicare price negotiations implementation.